Sleeping sickness parasite reveals enzyme weak spot that could guide safer drugs
African sleeping sickness and related diseases can be treated only with toxic and sometimes ineffective drugs. Now, University of Connecticut researchers show in Nucleic Acids Research that a crucial enzyme could be the key to safer, more effective medicines.
African sleeping sickness and related diseases can be treated only with toxic and sometimes ineffective drugs. Now, University of Connecticut researchers show in Nucleic Acids Research that a crucial enzyme could be the key to safer, more effective medicines. This story matters for Science & Discovery readers tracking mech. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. MechNews.com curates and briefs the science & discovery stories that matter. Our editorial policy →
Get the daily mech signal